First-line Treatment of Non-Small Cell Lung Cancer Under Routine Conditions: Observational Study on Overall Survival.
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2012
At a glance
- Drugs Antineoplastics; Gemcitabine; Pemetrexed; Platinum complexes; Taxanes; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms FRAME
- 23 Aug 2012 Actual end date (1 Jul 2012) added as reported by ClinicalTrials.gov record.
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.